More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$5.61B
EPS
-7.29
P/E ratio
--
Price to sales
1.76
Dividend yield
1.072%
Beta
0.953134
Previous close
$127.25
Today's open
$127.43
Day's range
$125.72 - $127.97
52 week range
$102.58 - $185.94
show more
CEO
Liam J. Kelly
Employees
14100
Headquarters
Wayne, PA
Exchange
New York Stock Exchange
Shares outstanding
44194408
Issue type
Common Stock
Healthcare
Medical Equipment & Supplies
Teleflex: Selling, But How Much?
Teleflex Incorporated rebounded from lows after announcing a $2.03B divestiture of Acute Care, Interventional Urology, and OEM businesses. TFX will use $1B of net proceeds for share buybacks, reducing pro forma net debt to $1.5B, but revenue impact remains ambiguous. Shares now trade at 10x adjusted earnings, with market reaction positive despite uncertainty around divested revenue figures.
Seeking Alpha • Dec 10, 2025

Teleflex to sell three of its businesses for $2.03 billion
Medical device maker Teleflex said on Tuesday it will sell three of its business units for a total of $2.03 billion in cash.
Reuters • Dec 9, 2025

Montagu and Kohlberg to Acquire Teleflex Medical OEM in a Carve-out Transaction
NEW YORK--(BUSINESS WIRE)--Montagu and Kohlberg, two leading middle-market private equity firms, today announced that they have entered into a definitive agreement to acquire Teleflex Medical OEM (the “Company”) from Teleflex Incorporated (NYSE: TFX) for $1.5 billion in a carve-out transaction. For over 40 years, Teleflex Medical OEM has developed and supplied custom-engineered interventional catheter components and sub-assemblies, as well as surgical fibers and sutures, used across fast-growin.
Business Wire • Dec 9, 2025

Teleflex Announces Sale of Acute Care, Interventional Urology, and OEM Businesses for $2.03 Billion
Board of Directors authorizes new $1 billion share repurchase program Board of Directors authorizes new $1 billion share repurchase program
GlobeNewsWire • Dec 9, 2025

Teleflex Incorporated (TFX) Presents at Jefferies London Healthcare Conference 2025 Transcript
Teleflex Incorporated ( TFX ) Jefferies London Healthcare Conference 2025 November 18, 2025 5:00 AM EST Company Participants Liam Kelly - Chairman, President & CEO Conference Call Participants Matthew Taylor - Jefferies LLC, Research Division Presentation Matthew Taylor Jefferies LLC, Research Division Great. Thanks for joining us here for our next session.
Seeking Alpha • Nov 18, 2025

Don't Overlook Teleflex (TFX) International Revenue Trends While Assessing the Stock
Explore Teleflex's (TFX) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.
Zacks Investment Research • Nov 17, 2025

Teleflex Incorporated (TFX) Discusses Strategic Rationale and Portfolio Overview of Acquired Vascular Intervention Business Transcript
Teleflex Incorporated ( TFX ) Discusses Strategic Rationale and Portfolio Overview of Acquired Vascular Intervention Business November 14, 2025 8:00 AM EST Company Participants Lawrence Keusch - Vice President of Investor Relations & Strategy Development Thierry Glauser Christopher Buller Liam Kelly - Chairman, President & CEO Conference Call Participants Kevin Croce Elliot Smith Patrick Wood - Morgan Stanley, Research Division Ravi Misra - Truist Securities, Inc., Research Division Larry Biegelsen - Wells Fargo Securities, LLC, Research Division Matthew O'Brien - Piper Sandler & Co., Research Division Shagun Singh Chadha - RBC Capital Markets, Research Division Presentation Operator Good morning, ladies and gentlemen, and welcome to the Teleflex Vascular Intervention Investor Meeting. [Operator Instructions] Please note that this conference call is being recorded and will be available on the company's website for replay shortly.
Seeking Alpha • Nov 14, 2025

Teleflex to Present at the Jefferies Global Healthcare Conference in London
WAYNE, Pa., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Management of Teleflex Incorporated (NYSE: TFX) is scheduled to speak at the Jefferies Global Healthcare Conference in London on Tuesday, November 18, 2025, at 10:00 a.m. (GMT).
GlobeNewsWire • Nov 14, 2025

TFX Stock Falls Despite Q3 Earnings and Revenue Beat, '25 View Down
Teleflex posts strong Q3 earnings and revenue beats but trims 2025 outlook, sending shares slightly lower.
Zacks Investment Research • Nov 13, 2025

These Analysts Cut Their Forecasts On Teleflex Following Q3 Results
Teleflex Incorporated (NYSE:TFX) reported better-than-expected earnings for the third quarter on Thursday.
Benzinga • Nov 7, 2025

¹ Disclosures

Open an M1 investment account to buy and sell Teleflex Incorporated commission-free¹. Build wealth for the long term using automated trading and transfers.